Durham, NC, United States of America

Katherine Stetson

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2009-2014.


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Katherine Stetson: Innovator in Chemical Compounds

Introduction

Katherine Stetson is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of chemical compounds, particularly in the development of non-steroidal compounds that modulate androgen receptors. With a total of 3 patents to her name, her work has the potential to impact various applications in medicine and biochemistry.

Latest Patents

Katherine's latest patents focus on innovative chemical compounds. These inventions relate to non-steroidal compounds that serve as modulators of androgen receptors. Additionally, her patents detail the methods for the making and use of such compounds, showcasing her expertise in this specialized area.

Career Highlights

Throughout her career, Katherine has worked with notable companies such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Katherine has collaborated with esteemed colleagues, including Andrew Lamont Larkin and Huiquiang Zhou. These partnerships have further enriched her work and expanded the scope of her research.

Conclusion

Katherine Stetson stands out as an influential inventor in the realm of chemical compounds. Her innovative patents and collaborations reflect her dedication to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…